These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317 [TBL] [Abstract][Full Text] [Related]
43. Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization. Tuttle SE; Jewell SD; Mojzisik CM; Hinkle GH; Colcher D; Schlom J; Martin EW Int J Cancer; 1988 Sep; 42(3):352-8. PubMed ID: 3417363 [TBL] [Abstract][Full Text] [Related]
44. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen. Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705 [TBL] [Abstract][Full Text] [Related]
45. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil). Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118 [TBL] [Abstract][Full Text] [Related]
46. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts. Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830 [TBL] [Abstract][Full Text] [Related]
47. Radioimmunodetection of human colon carcinoma xenografts in visceral organs of congenitally athymic mice. Lundy J; Mornex F; Keenan AM; Greiner JW; Colcher D Cancer; 1986 Feb; 57(3):503-9. PubMed ID: 3942982 [TBL] [Abstract][Full Text] [Related]
48. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients. Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989 [TBL] [Abstract][Full Text] [Related]
49. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial. Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170 [TBL] [Abstract][Full Text] [Related]
51. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody. Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655 [TBL] [Abstract][Full Text] [Related]
52. Radioimmunodetection of small human tumor xenografts in spleen of athymic mice by monoclonal antibodies. Shah SA; Gallagher BM; Sands H Cancer Res; 1985 Nov; 45(11 Pt 2):5824-9. PubMed ID: 4053053 [TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody. Chen FM; Taylor CR; Epstein AL Cancer Res; 1989 Aug; 49(16):4578-85. PubMed ID: 2743341 [TBL] [Abstract][Full Text] [Related]
54. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis. DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487 [TBL] [Abstract][Full Text] [Related]
55. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. Welt S; Divgi CR; Kemeny N; Finn RD; Scott AM; Graham M; Germain JS; Richards EC; Larson SM; Oettgen HF J Clin Oncol; 1994 Aug; 12(8):1561-71. PubMed ID: 8040668 [TBL] [Abstract][Full Text] [Related]
56. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts. Esteban JM; Schlom J; Gansow OA; Atcher RW; Brechbiel MW; Simpson DE; Colcher D J Nucl Med; 1987 May; 28(5):861-70. PubMed ID: 3106595 [TBL] [Abstract][Full Text] [Related]
57. Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10. Yu MH; Roffler SR; Hwang WS; Tung E; Chen WL; Yeh MY Gynecol Oncol; 1992 Oct; 47(1):93-101. PubMed ID: 1427409 [TBL] [Abstract][Full Text] [Related]
58. Autoradiographic analysis of monoclonal antibody distribution in human colon and breast tumor xenografts. Jones PL; Gallagher BM; Sands H Cancer Immunol Immunother; 1986; 22(2):139-43. PubMed ID: 3719593 [TBL] [Abstract][Full Text] [Related]
59. Comparative biodistribution and radioimmunotherapy of monoclonal antibody RS7 and its F(ab')2 in nude mice bearing human tumor xenografts. Stein R; Blumenthal R; Sharkey RM; Goldenberg DM Cancer; 1994 Feb; 73(3 Suppl):816-23. PubMed ID: 8306265 [TBL] [Abstract][Full Text] [Related]
60. [In vivo application of monoclonal antibodies in the management of human carcinomas]. Ohuchi N; Colcher D; Schlom J Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1109-14. PubMed ID: 3291770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]